GAVI Vaccines Unlock $30 Billion Economic Return in Lower-Income Markets — 全球疫苗联盟在低收入市场释放三百亿美元经济回报

核心机制与资金流向

In 2025 alone, vaccine programmes backed by GAVI yielded economic returns exceeding US$30 billion across lower-income nations by cutting public health spending and boosting workforce productivity through routine inoculation drives. The Geneva-based alliance channels procurement funds through UNICEF and WHO to 57 eligible nations, creating pooled demand that directly lowers unit costs for governments. Finalised in October 2026, this annual impact assessment confirms the revenue pool available to certified suppliers under the previous strategic cycle.

全球疫苗免疫联盟支持的接种项目在2025年内通过常规疫苗运动削减公共卫生支出并提升工作生产力，为低收入国家带来超过300亿美元的经济回报。这家总部位于日内瓦的联盟通过联合国儿童基金会和世卫组织向57个符合资格的国家输送采购资金，形成联合需求结构，直接降低了各国政府的单剂采购成本。该年度影响评估于2026年10月最终确认，核定了上一战略周期内向认证供应商开放的资金池规模。

五年筹资规模与新周期衔接

At the 2020 Global Vaccine Summit, donors pledged US$8.8 billion to fund GAVI's 2021–2025 strategic period, making it one of the largest health-financing pools for developing economies. That five-year envelope financed vaccine doses, cold-chain infrastructure, and health-worker training for 300 million children. With the 2026–2030 cycle now underway, new multiyear purchase agreements are being signed through UNICEF Supply Division for the next replenishment phase.

在2020年全球疫苗峰会上，捐助方承诺提供88亿美元资助GAVI 2021至2025战略周期，这使其成为发展中经济体最大的卫生资金池之一。该五年期资金包为3亿名儿童提供了疫苗剂次、冷链基础设施和卫生工作者培训。随着2026至2030年新周期现已启动，联合国儿童基金会供应司正为下一阶段的补充资金签署新的多年期采购协议。

供应商准入门槛与采购数据

| 准入指标 | 具体要求 | 备注 |

|---------|---------|------|

| WHO预认证（PQ） | 审核周期18–24个月 | 疫苗与冷链设备均适用 |

| UNICEF供应商注册 | 年度合规审查 | 通过UNGM平台提交 |

| 历史覆盖规模 | 3亿名儿童（2021-2025） | GAVI 5.0完成量 |

Manufacturers seeking entry must first secure WHO Prequalification, a process that typically spans 18 to 24 months for vaccines and cold-chain equipment. UNICEF supplier registration follows through the UN Global Marketplace, requiring annual compliance audits. The previous GAVI 5.0 cycle reached 300 million children, demonstrating sustained procurement volume for vendors who clear these gates.

寻求进入的制造商必须首先获得世卫组织预认证，疫苗和冷链设备的审核周期通常为18至24个月。随后通过联合国全球 Marketplace平台完成联合国儿童基金会供应商注册，并接受年度合规审计。GAVI 5.0周期覆盖了3亿名儿童，这证明通过上述门槛的供应商将获得持续采购量。

企业该做什么

- 已有医疗器械资质的：立即启动WHO PQ申请，优先申报肺炎球菌和轮状病毒疫苗，这两款产品常年占据GAVI采购预算的头部份额。

- 冷链物流商：与肯尼亚蒙巴萨或南非德班的现有保税仓谈判合资，GAVI新周期在非洲的冷链仓储需求仍在扩容。

- 观望者：GAVI 6.0（2026-2030）资金池已生效，应在2026年12月前完成UNGM注册，锁定2027年度采购计划席位。

Enterprises with existing medical-device licences should immediately initiate WHO PQ applications, prioritising pneumococcal and rotavirus vaccines that command the largest shares of GAVI procurement budgets. Cold-chain logistics operators should negotiate joint ventures at bonded warehouses in Mombasa or Durban, where GAVI-financed cold-chain demand continues to expand under the new 2026–2030 cycle. Companies still observing should note the GAVI 6.0 fund is already active; complete UNGM registration before December 2026 to secure slots in the 2027 procurement plan.

已有医疗器械资质的企业应立即启动世卫组织预认证申请，优先申报肺炎球菌和轮状病毒疫苗，这两种产品常年占据GAVI采购预算的最大份额。冷链物流商应与肯尼亚蒙巴萨或南非德班的现有保税仓谈判合资，GAVI新周期在非洲的冷链仓储需求仍在扩容。观望中的企业应注意GAVI 6.0（2026-2030）资金池已生效，应在2026年12月前完成UNGM注册，以锁定2027年度采购计划席位。

对企业出海的意义

第一步登录UNICEF Supply Division网站下载2027年度招标品类清单，核实产品是否属于GAVI资助目录。第二步在2026年11月前向世卫组织提交预认证意向书，并在同年12月前完成UNGM供应商档案激活。第三步指派专职团队对接加纳、肯尼亚或越南的卫生部采购办公室，因为GAVI要求受援国政府按收入分级支付部分疫苗费用，本土部门的采购话语权正在持续加大。

First, download the 2027 annual tender list from the UNICEF Supply Division website and verify whether your product falls within GAVI-funded categories. Second, submit a WHO prequalification intent before November 2026 and activate your UNGM supplier profile by December 2026. Third, assign a dedicated team to procurement offices in the health ministries of Ghana, Kenya, or Vietnam, because GAVI requires recipient governments to pay graded portions of vaccine costs based on income levels, steadily increasing local procurement authority.